Scott Robert Ainsider trades
In SEC Form 4 filings, Scott Robert A is listed as Director of Arcutis Biotherapeutics, Inc. (ARQT). Scott Robert A reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 28.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ARQTArcutis Biotherapeutics, Inc. | Director | 3 | Oct 28 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-28
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ARQTArcutis Biotherapeutics, Inc. | Oct 23 | Oct 28 | A | 2,819 | $0.00 | $0 | 2,819 | No | Form 4 |
| ARQTArcutis Biotherapeutics, Inc. | Oct 23 | Oct 28 | A · derivative | 20,507 | $31.20 | $639,818 | 20,507 | No | Form 4 |
| ARQTArcutis Biotherapeutics, Inc. | Oct 23 | Oct 28 | A · derivative | 8,663 | $31.20 | $270,286 | 8,663 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.